English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

In the present study, a new series of (bis)ureas  11 ( a–f ) and (bis)thioureas  13 ( a–f ) of 3,3'-dimethoxy-[1,1'-biphenyl]-4,4'-diamine dihydrochloride ( 9 ) has been synthesized. This precursor intermediate  9  in high yields was preparedfrom the commercial starting material, 4,4'-dinitro-[1,1'-biphenyl]-3,3'-diol ( 7 ) by following the chemical transformations such as methylation of hydroxyl groups and reduction of nitro to an amine functionality. Antimicrobial and antioxidant activities of the synthesized compounds were evaluated to screen for their biological significance. Antimicrobial activity screening results against four bacteria and two fungi unveiled that a few compounds,  11 b / 13b ,  11e / 13e,  and  11d  (MIC 3.125 − 6.25 µg/ml) against all the tested bacterial strains and compound  11d  against  Cladosporium species  (MIC 3.125 µg/ml) having potential activity. Especially, (bis)urea compounds  11a ,  11 b , and  11e , and (bis)thiourea compounds  13a ,  13d , and  13f  (MIC 3.125 µg/ml) are proved the comparable activity with standard, cefixime (MIC 3.125 µg/ml) against  P. aeruginosa . On the other hand, a few compounds  11c / 13c ,  13d,  and  11e / 13e  were found, by using DPPH and FRAP methods, to exhibit a good antioxidant activity (IC 50  range 25.0–32.5 µg/ml). The synthesized compounds were docked well in the active site of an enzyme, DNA Gyrase A, and the predictions of in silico-ADME and pharmacokinetic parameters suggest that the compounds have good oral bioavailability. The results demonstrate that this class of compounds has an expedient scope to use as antibacterial and antioxidant agents upon further development.

polycyclic aromatic compounds

Biphenyl Backbone-Based (Bis)Urea and (Bis)Thiourea Derivatives as Antimicrobial and Antioxidant Agents and Evaluation of Docking Studies and ADME Properties